ExodusPoint Capital Management LP Makes New $6.27 Million Investment in Encompass Health Co. (NYSE:EHC)

ExodusPoint Capital Management LP bought a new stake in Encompass Health Co. (NYSE:EHC) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 67,870 shares of the company’s stock, valued at approximately $6,268,000.

A number of other hedge funds and other institutional investors have also modified their holdings of EHC. Miracle Mile Advisors LLC grew its holdings in shares of Encompass Health by 3.0% in the fourth quarter. Miracle Mile Advisors LLC now owns 3,835 shares of the company’s stock valued at $354,000 after purchasing an additional 112 shares during the period. US Bancorp DE grew its stake in shares of Encompass Health by 9.6% in the 4th quarter. US Bancorp DE now owns 1,380 shares of the company’s stock valued at $127,000 after buying an additional 121 shares during the period. Signaturefd LLC grew its stake in shares of Encompass Health by 21.6% in the 4th quarter. Signaturefd LLC now owns 704 shares of the company’s stock valued at $65,000 after buying an additional 125 shares during the period. CBIZ Investment Advisory Services LLC raised its position in shares of Encompass Health by 38.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock valued at $42,000 after buying an additional 127 shares during the period. Finally, MassMutual Private Wealth & Trust FSB lifted its holdings in Encompass Health by 87.8% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after acquiring an additional 137 shares during the last quarter. 97.25% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

EHC has been the subject of several recent analyst reports. Royal Bank of Canada reissued an “outperform” rating and set a $110.00 target price on shares of Encompass Health in a research note on Tuesday, February 11th. William Blair reissued an “outperform” rating on shares of Encompass Health in a research report on Friday, February 7th. StockNews.com cut shares of Encompass Health from a “buy” rating to a “hold” rating in a research report on Thursday. KeyCorp lifted their price target on shares of Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a research report on Monday, February 10th. Finally, Barclays boosted their price target on shares of Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, February 7th. One equities research analyst has rated the stock with a hold rating, nine have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $107.67.

Encompass Health Price Performance

Shares of EHC opened at $98.14 on Friday. The company has a market cap of $9.88 billion, a P/E ratio of 22.00, a PEG ratio of 2.31 and a beta of 0.87. Encompass Health Co. has a fifty-two week low of $78.53 and a fifty-two week high of $104.55. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. The firm’s 50 day moving average price is $99.25 and its 200 day moving average price is $97.71.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, topping analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. On average, research analysts forecast that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be paid a dividend of $0.17 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.69%. Encompass Health’s payout ratio is 15.25%.

Insider Buying and Selling

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the sale, the chief accounting officer now directly owns 69,164 shares of the company’s stock, valued at approximately $6,798,129.56. This represents a 6.79 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Insiders own 2.10% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.